Thalidomide News and Research

RSS
Thalidomide is a drug that is used to treat multiple myeloma in patients who have just been diagnosed, and a painful skin disease related to leprosy. It is also being studied in the treatment of other types of cancer. Thalidomide belongs to the family of drugs called angiogenesis inhibitors. Also called Thalomid.
New data on ZOLINZA (vorinostat) in combination with Bortezomib

New data on ZOLINZA (vorinostat) in combination with Bortezomib

Drug combo improves or stabilizes disease for relapsed multiple myeloma patients

Drug combo improves or stabilizes disease for relapsed multiple myeloma patients

FDA deadlines may compromise drug safety by rushing approval

FDA deadlines may compromise drug safety by rushing approval

Thalidomide shows promise for treatment of recurrent ovarian cancer

Thalidomide shows promise for treatment of recurrent ovarian cancer

New way to grow blood vessels

New way to grow blood vessels

Velcade, lenalidomide and dexamethasone combo show promise for multiple myeloma

Velcade, lenalidomide and dexamethasone combo show promise for multiple myeloma

Lenalidomide - dexamethasone combination effective against multiple myeloma

Lenalidomide - dexamethasone combination effective against multiple myeloma

Studies attribute recent increase in multiple myeloma survival to novel therapies

Studies attribute recent increase in multiple myeloma survival to novel therapies

Thalidomide therapy helps elderly myeloma patients live longer

Thalidomide therapy helps elderly myeloma patients live longer

New pregnancy labeling rules should be approved without delay

New pregnancy labeling rules should be approved without delay

50 million Europeans suffer from neurological diseases

50 million Europeans suffer from neurological diseases

Multiple myeloma dexamethasone / lenalidomide trial closes

Multiple myeloma dexamethasone / lenalidomide trial closes

Method for making new molecules based on flavonoids - implications for cancer therapeutics

Method for making new molecules based on flavonoids - implications for cancer therapeutics

Roswell Park research aids development of myeloma drug

Roswell Park research aids development of myeloma drug

Thalomid gets FDA approval to treat multiple myeloma

Thalomid gets FDA approval to treat multiple myeloma

Natural killer cells and antibody-based immune function

Natural killer cells and antibody-based immune function

First trial to combine a biologic agent with a conventional chemotherapy agent for the treatment of ovarian cancer

First trial to combine a biologic agent with a conventional chemotherapy agent for the treatment of ovarian cancer

Therapy for metastatic renal cell carcinoma remains inadequate

Therapy for metastatic renal cell carcinoma remains inadequate

Thalidomide, Lenalidomide show promise against Lou Gehrig's disease

Thalidomide, Lenalidomide show promise against Lou Gehrig's disease

Thalidomide improves remission in myeloma

Thalidomide improves remission in myeloma